COPENHAGEN, Denmark and BOSTON, Sept. 21, 2021 /PRNewswire/ -- Hemab ApS ("Hemab"), a biotech company developing next generation therapeutics for serious underserved bleeding and thrombosis disorders, today announces the appointment of Mads Behrndt as Chief Financial Officer. Mads brings...
from PR Newswire: https://ift.tt/3hR780C
No comments:
Post a Comment